Apyx Medical Corp.
- APYX · Nasdaq
- Surgical & Medical Instruments & Apparatus
- Clearwater, FL
- 205 employees
- CIK 0000719135
Updated from SEC filings through
Top things to know
Executives
- Charles D. Goodwin II Chief Executive Officer 4, 2026-06-15
- Matthew C. Hill Chief Financial Officer 4, 2026-06-15
- Shawn David Roman Chief Operating Officer 4, 2026-06-17
- Moshe Citronowicz Sr. V.P. of Operations 4, 2026-06-15
- Stavros Vizirgianakis Chairperson of the Board 10-K, 2026-03-10
- Matthew Hill Chief Financial Officer, Treasurer and Secretary DEF 14A, 2026-06-26
What leadership is saying
“We are pleased to report 17% growth in our Surgical Aesthetics business for the quarter, reflecting continued adoption of AYON and the progress we are making in executing our commercial strategy”
Earnings press release (8-K Ex. 99.1), filed November 5, 2026
Apyx Medical Corp is a U.S. public company in surgical & medical instruments & apparatus (SIC 3841), headquartered in Clearwater, FL. It trades as APYX on Nasdaq. Revenue was $52.8M in the fiscal year ending December 31, 2025, +9.9% from the year before. It reported about 205 employees. Charles D. Goodwin II is Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $52.8M 10-K, 2026-03-10 | $48.1M 10-K, 2026-03-10 | $52.3M 10-K, 2025-03-13 | $44.5M 10-K, 2024-03-21 | $48.5M 10-K, 2023-03-16 |
| Operating income | -$6.4M 10-K, 2026-03-10 | -$18.8M 10-K, 2026-03-10 | -$17.3M 10-K, 2025-03-13 | -$23.6M 10-K, 2024-03-21 | -$14.4M 10-K, 2023-03-16 |
| SG&A | $15.8M 10-K, 2026-03-10 | $18.9M 10-K, 2026-03-10 | $22.2M 10-K, 2025-03-13 | $20.5M 10-K, 2024-03-21 | $18.6M 10-K, 2023-03-16 |
| Net income | -$11.2M 10-K, 2026-03-10 | -$23.5M 10-K, 2026-03-10 | -$18.7M 10-K, 2025-03-13 | -$23.2M 10-K, 2024-03-21 | -$15.2M 10-K, 2023-03-16 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Charles D. Goodwin II President & Chief Executive Officer at Apyx Medical Corporation | Chief Executive Officer | 4, 2026-06-15 |
| Matthew Hill | Named in proxy bio: Chief Financial Officer, Treasurer and Secretary | DEF 14A, 2026-06-26 |
| Matthew C. Hill | Chief Financial Officer | 4, 2026-06-15 |
| Shawn Roman | Named in proxy bio: Chief Operating Officer | DEF 14A, 2026-06-26 |
| Shawn David Roman | Chief Operating Officer | 4, 2026-06-17 |
| Moshe Citronowicz | Sr. V.P. of Operations | 4, 2026-06-15 |
| Stavros Vizirgianakis | Chairperson of the Board | 10-K, 2026-03-10 |
| Lawrence J. Waldman | Director | 10-K, 2026-03-10 |
| Minnie Baylor-Henry | Director | 10-K, 2026-03-10 |
| Wendy Levine | Director | 10-K, 2026-03-10 |
What Apyx Medical Corp does
Apyx Medical Corporation (“Company”, “Apyx Medical”, “we”, “us”, or “our”) was incorporated in 1982, under the laws of the State of Delaware and has its principal executive office at 5115 Ulmerton Road, Clearwater, FL 33760.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 42.1 million (as of November 4, 2026) | 10-Q, November 5, 2026 |
|---|---|---|
| Public float | $79.8M (as of June 30, 2025) | 10-K, March 10, 2026 |
| Reportable segments | 2 (period ending September 30, 2026) | 10-Q, November 5, 2026 |
| Latest proxy statement | Meeting December 31, 2025 (filed June 26, 2026) | DEF 14A, June 26, 2026 |
| Auditor | Rsm Us LLP (Tampa, Florida) | Latest 10-K |
Recent 8-K events
- 8-K filed 2026-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-09-29
- Item 8.01 Other events
- 8-K filed 2026-08-07
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-08-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-07-24
- Item 8.01 Other events
- 8-K filed 2026-06-17
- Item 1.01 Entry into a material definitive agreement
- 8-K filed 2026-05-21
- Item 8.01 Other events
- 8-K filed 2026-05-14
- Item 8.01 Other events
- 8-K filed 2026-05-11
- Item 8.01 Other events
- 8-K filed 2026-05-07
- Item 2.02 Results of operations and financial condition (earnings release)
Frequently asked questions about Apyx Medical Corp
- What does Apyx Medical Corp do?
- In its own words, from Item 1 of its 10-K: "Apyx Medical Corporation (“Company”, “Apyx Medical”, “we”, “us”, or “our”) was incorporated in 1982, under the laws of the State of Delaware and has its principal executive office at 5115 Ulmerton Road, Clearwater, FL 33760."
- What is Apyx Medical Corp's revenue?
- $52.8M for the fiscal year ending December 31, 2025, from its 10-K filed March 10, 2026.
- Is Apyx Medical Corp profitable?
- Apyx Medical Corp reported net income of -$11.2M for the fiscal year ending December 31, 2025.
- How many employees does Apyx Medical Corp have?
- About 205 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Apyx Medical Corp?
- Charles D. Goodwin II, Chief Executive Officer, as named in a 4 filed June 15, 2026.
- Who is the CFO of Apyx Medical Corp?
- Matthew C. Hill, Chief Financial Officer, as named in a 4 filed June 15, 2026.
- Where is Apyx Medical Corp headquartered?
- Clearwater, FL.
- What is Apyx Medical Corp's stock ticker?
- APYX on Nasdaq.
- What industry is Apyx Medical Corp in?
- Surgical & Medical Instruments & Apparatus, SIC code 3841.
- What is Apyx Medical Corp's website?
- apyxmedical.com.
- When does Apyx Medical Corp report earnings next?
- December 18, 2026. Source: estimate_8k_pattern.
- Is Apyx Medical Corp a public company?
- Yes. Apyx Medical Corp files with the SEC under CIK 0000719135 and trades as APYX.
- Who audits Apyx Medical Corp?
- Rsm Us LLP, Tampa, Florida, as named in its latest annual report (10-K).
- How many shares of Apyx Medical Corp are outstanding?
- 42.1 million shares as of November 4, 2026, from its 10-Q filed November 5, 2026.
- What is Apyx Medical Corp's public float?
- $79.8M as of June 30, 2025, as reported on the cover of its 10-K filed March 10, 2026.
- How many business segments does Apyx Medical Corp report?
- 2 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 5, 2026.
- When is Apyx Medical Corp's annual shareholder meeting?
- December 31, 2025, per its proxy statement (DEF 14A) filed June 26, 2026.